WOODHOUSE DAVID J (CEO and acting CFO) received a stock award from NGM BIOPHARMACEUTICALS INC
Compensation award — not an open‑market transaction. Less informative as a directional signal.
A · 1 award
Filed: 3/6/2023ACC: 0001209191-23-016396
DirectorOfficer· CEO and acting CFO
Since Apr 2019
+1.01M
Net shares
Net buyer
$0.00
Total acquired
0
Open market trades
0B · 0S
3
Total transactions
1.01M acquired
Non-Derivative Transactions1
Common Stock
Direct
Shares
+127.20K
Price / share
—
Trade value
—
% of position
720.5%
3/2/2023
17.65K→144.85K
Total
Net shares
+127.20K
Net value
$0.00
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 3/2/2023 | A · Award | +127.20K | — | — | 720.5% | 17.65K | 144.85K |
| Total | +127.20K | $0.00 | ||||||
Derivative Transactions2
Stock Option (Right to Buy)
Direct
Converts to
Common Stock
381.60K shares
Shares
+381.60K
Strike price
4.36
Held after
381.60K
Exercisable
—
3/2/2023
Stock Option (Right to Buy)
Direct
Converts to
Common Stock
500K shares
Shares
+500K
Strike price
4.36
Held after
500K
Exercisable
—
3/2/2023
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy) Direct | Common Stock381.60K shares | 3/2/2023 | A · Award | +381.60K | 4.36 | — | 381.60K |
| Stock Option (Right to Buy) Direct | Common Stock500K shares | 3/2/2023 | A · Award | +500K | 4.36 | — | 500K |
Non-Derivative Holdings (Post-Transaction)1
Common Stock
IndirectShares owned80K
Total
80K indirect80K
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common Stock | 80K | Indirect |
| Total | 80K | 80K indirect |
Derivative Holdings (Post-Transaction)0
No derivative holdings reported